Alterations of p53, cyclin D1 and pRB expression in the carcinogenesis of esophageal squamous cell carcinoma

Oncology Reports

Volumn 14, Issue 6, 2005, Pages 1453-1459

  Kawakubo, H ^a   Ozawa, S ^a   Ando, N ^b   Kitagawa, Y ^a   Mukai, M ^a   Ueda, M ^a   Kitajima, M ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO DENTAL COLLEGE   (Japan)

Author keywords

cyclin D1; Dysplasia; Iodine unstained lesion; ki67; p53; pRB

Indexed keywords

CYCLIN D1; PROTEIN P53; RETINOBLASTOMA PROTEIN; TUMOR PROTEIN;

ARTICLE; BIOSYNTHESIS; CHEMISTRY; COMPARATIVE STUDY; ESOPHAGITIS; ESOPHAGUS; ESOPHAGUS TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; PRECANCER; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CYCLIN D1; ESOPHAGEAL NEOPLASMS; ESOPHAGITIS; ESOPHAGUS; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM PROTEINS; PRECANCEROUS CONDITIONS; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33644675173     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.14.6.1453     Document Type: Article

References (45)

1. Yoshida S: Endoscopic diagnosis and treatment of early cancer in the alimentary tract. Digestion 59: 502-508, 1998.
2. Makuuchi H, Machimura T, Mizutani K, et al: Controversy in the treatment for superficial esophageal carcinoma: indications and problems of the procedures (in Japanese with English abstract). J Jpn Surg Soc 93: 1059-1062, 1992.
3. Kumagai Y, Makuuchi H, Mitomi T and Ohmori T: A new classification system for early carcinomas of the esophagus. Dig Endosc 5: 139-150, 1993. (Pubitemid 23185491)
4. Lambert R: Endoscopic treament of esophagogastric tumors (Review). Endoscopy 28: 27-37, 1996.
5. Dawsey SM, Fleischer DE, Wang GQ, et al: Mucosal iodine staining improves endoscopic visualization of squamous dysplasia and squamous cell carcinoma of the esophagus in Linzian, China. Cancer 83: 220-231, 1998. (Pubitemid 28317800)
6. Martin IG, Young S, Sue-Ling H and Johnston D: Delays in the diagnosis of oesophagogastric cancer: a consecutive case series. BMJ 314: 467-470, 1997.
7. Morita M, Kuwano H, Yasuda M, et al: The multicentric occurrence of squamous epithelial dysplasia and squamous cell carcinoma in the esophagus. Cancer 74: 2889-2995, 1994.
8. Yang CS: Reserch on esophageal cancer in China (Review). Cancer Res 40: 2633-2644, 1980.
9. Correa P: Precusors of gastric and esophageal cancer. Cancer 50: 2554-2565, 1982.
10. Qiu SL and Yang GR: Precursor lesions of esophageal cancer in high-risk populations in Henan Province, China. Cancer 62: 551-557, 1988.
11. Wang LD, Lipkin M, Qui SL, Yang GR, Yang CS and Newmark HL: Labeling index and labeling distribution of cells in the esophageal epithelium in individuals at increased risk for esophageal cancer in Huixian China. Cancer Res 50: 2651-2653, 1990. (Pubitemid 20150199)
12. Endo M, Takeshita K and Yoshida M: How can we diagnose the early stage of esophageal cancer? Endoscopy 18: 11-18, 1986. (Pubitemid 16038841)
13. Sugimachi K, Ohno S, Matsuda H, Mori M and Kuwano H: Lugol-combined endoscopic detection of minute malignant lesions of the thoracic esophagus. Ann Surg 208: 179-183, 1988.
14. Yokoyama A, Ohmori T, Makuuchi H, et al: Successful screening for early esophageal cancer in alcoholics using endoscopy and mucosa iodine staining. Cancer 76: 928-934, 1995.
15. Hunter T and Pines J: Cyclins and cancer. Cyclin D and CDK inhibitors come of age. Cell 79: 573-582, 1994. (Pubitemid 24363801)
16. Takeuchi H, Ozawa S, Ando N, et al: Further evidence that altered p16/CDKN2 gene expression is associated with lymph node metastasis in squamous cell carcinoma of the esophagus. Oncol Report 8: 627-632, 2001.
17. Montesano R, Hollstein M and Hainaut P: Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis (Review). Int J Cancer 69: 225-235, 1996. (Pubitemid 26233303)
18. Matsushime H, Roussel MF, Ashumun RA and Sherr CJ: Colony-stimulating factor1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 65: 701-713, 1991.
19. Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV and Kronenberg HM: A novel cyclin encoded by a bel1-linked candidate oncogene. Nature 350: 512-515, 1991. (Pubitemid 21912266)
20. Tam SW, Theodoras AM, Shay JW, Draetta GF and Pagano M: Differential expression and regulation of Cyclin D1 protein in normal and tumor human cells: association with Cdk4 is required for Cyclin D1 function in G1 progression. Oncogene 9: 2663-2674, 1994. (Pubitemid 24254043)
21. Koyanagi K, Ozawa S, Ando N, et al: Telomerase activity as an indicator of malignant potential in iodine-nonreactive lesions of the esophagus. Cancer 88: 1524-1529, 2000. (Pubitemid 30183135)
22. Roncalli M, Bosari S, Marchetti A, et al: Cell cycle-related gene abnormalities and product expression in esophageal carcinoma. Lab Invest 78-79: 1049-1057, 1998. (Pubitemid 28440821)
23. Takeuchi H, Ozawa S, Ando N, Shih CH, Koyanagi K, Ueda M and Kitajima M: Altered p16/MTS1/CDKN2 and cyclin D1/PRAD-1 gene expression is associated with the prognosis of squamous cell carcinoma of the esophagus. Clin Cancer Res 3: 2229-2236, 1997. (Pubitemid 28133140)
24. Natsugoe S, Nakashima S, Matsumoto M, et al: Expression of p21WAF1/Cip1 in the p53-dependent pathway is related to prognosis in patients with advanced esophageal carcinoma. Clin Cancer Res 5: 2445-2449, 1999. (Pubitemid 29437326)
25. Schlemper RJ, Dawsey SM, Itabashi M, et al: Differences in diagnostic criteria for esophageal squamous cell carcinoma between Japanese and Western pathologists. Cancer 88: 996-1006, 2000. (Pubitemid 30127658)
26. McCormick D, Chong H, Hobbs C, Datta C and Hall PA: Detection of the Ki67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB1. Histopathology 22: 355-360, 1993. (Pubitemid 23159796)
27. Wang LD, Zhou Q, Yang WC and Yang CS: Apoptosis and cell proliferation in esophageal precancerous and cancerous lesions: Study of a high-risk population in Northern China. Anticancer Res 19: 369-374, 1999. (Pubitemid 29168264)
28. Tatebe S, Ishida M, Kasagi N, Tsujitani S, Kaibara N and Ito H: Apoptosis occurs more frequently in metastatic foci than in primary lesions of human colorectal carcinomas: analysis by terminaldeoxynucleotide-transferase-mediated dUTP-niotin nick end labeling. Int J Cancer 65: 173-177, 1996.
29. Wang LD, Hong JY, Qiu SL, Gao H and Yang CS: Accumulation of p53 protein in human esophageal precancerous lesions: a possible early marker for carcinogenesis. Cancer Res 53: 1783-1787, 1993. (Pubitemid 23127103)
30. Parenti AR, Rugge M, Frizzera E, et al: p53 overexpression in the multistep process of esophageal carcinogenesis. Am J Surg Pathol 19: 1418-1422, 1995. (Pubitemid 3007347)
31. Wagata T, Shibagaki I, Imamura M, et al: Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinoma. Cancer Res 53: 846-850, 1993. (Pubitemid 23077872)
32. Naitoh H, Shibata J, Kawaguchi A, Kodama M and Hattori T: Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer. Am J Pathol 146: 1161-1169, 1995.
33. Shinozaki H, Ozawa S, Ando N, Tsuruta H, Terada M, Ueda M and Kitajima M: Cyclin D1 amplification as a new predictive classification for squamous cell carcinoma of the esophagus, adding gene information. Clin Cancer Res 2: 1151-1161, 1996.
34. Shamma A, Doki Y, Shiozaki H, et al: Effect of cyclin D1 and associated protein on proliferation of esophageal squamous cell carcinoma. Int J Oncol 13: 455-460, 1998. (Pubitemid 28372666)
35. Ohbu M, Kobayashi N and Okayasu I: Expression of cell cycle regulatory proteins in the multistep process of oesophageal carcinogenesis: stepwise over-expression of cyclin E and p53, reduction of p21 (WAF1/CIP1) and dysregulation of cyclin D1 and p27 (KIP1). Histopathology 39: 589-596, 2001. (Pubitemid 34017132)
36. Arber N, Hibshoosh H, Moss SF, et al: Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastroenterology 110: 669-674, 1996. (Pubitemid 26071834)
37. Cordon-Cardo C: Mutations of cell-cycle regulators. Am J Pathol 147: 545-560, 1995.
38. Harbour JW, Lai SL, Whang-Peng J, Gazdar AF, Minna JD and Kaye FJ: Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science 241: 353-356, 1998.
39. Lee EY, To H, Bookstein R, Scully P and Lee WH: Inactivation of the retinoblastoma susceptibility gene in human breast cancers. Science 241: 218-221, 1988.
40. Yandell DW, Campbell TA, Dayton SH, et al: Oncogenic point mutations in the human retinoblastoma gene: their application to genetic counseling. N Eng J Med 321: 1698-1705, 1989.
41. Jiang W, Zhang YJ, Kahn SM, et al: Altered expression of the cyclin D1 and retinoblastoma gene in human esophageal cancer. Proc Nat Acad Sci 90: 9026-9030, 1993. (Pubitemid 23306444)
42. Ishikawa T, Furihata M, Ohtsuki Y, Murakami H, Inoue A and Ogoshi S: Cyclin D1 over-expression related to retinoblastoma protein expression as a prognostic marker in human oesophageal squamous-cell carcinoma. Br J Cancer 77: 92-97, 1998. (Pubitemid 28029778)
43. Busatto G, Shiao YH, Parenti AR, et al: p16/CDKN2 alterations and pRB expression in oesophageal squamous cell carcinoma. Mol Pathol 51: 80-84, 1998. (Pubitemid 28261245)
44. Hausen AZ, Sarbia M, Heep H, Willers R and Gabbert HE: Retinoblastoma-protein (pRb) expression and prognosis in squamous-cell carcinoma of the esophagus. Int J Cancer 84: 618-622, 1999.
45. Kawakita N, Seki S, Sakaguchi H, et al: Immunohistochemical analysis of retinoblastoma gene product (pRB) expression in malignant and non-malignant liver disease. Liver 14: 295-301, 1994. (Pubitemid 24375388)